teresa kerr

Developed a new market while launching actionable and accurate hereditary cancer DNA insight testing to improve or maintain patient health and wellness.

* Award winning and top producing Business Development Manager with a strong track record of outperforming revenue goals, penetrating new markets and launching new products within highly competitive markets. * Part of first expansion sales team to launch revolutionary test to MFM, OBs,, health systems. * National award winner for bringing in the first commercial MaterniT21 test at launch. * Consistently #1 performer in Midwest Region. * Averaged 125% to goal each quarter

* Responsible for the marketing of medical cost containment services to insurance companies, third party administrators and self-insured corporations – directly or through insurance brokers. * Promoted to Regional Account Manager to oversee The Travelers account. * Expanded sales and services by 65% in a highly competitive market. * Considerably increased customer satisfaction and decreased account turnover.

* Business development and product marketing for molecular DNA human papillomavirus market. * Consulted healthcare professionals on organizational recommendations, guidelines, and treatment protocols. * Managed sales and marketing initiatives within laboratory and health system accounts. * Built and executed sales programs with client sales teams to foster technology adoption. * Finished 2009 at 98% to goal in spite of 51% increase in goals over previous year. * Ranked #1 in growth for the Region. * 50% average growth (38% growth 1st Quarter, 62% growth 2nd Quarter; 51% growth 3rd Quarter) * Averaged 120% to goals in 2007, 102% in 2008

Access Genetics offers a new paradigm for molecular testing. We provide web-based software, laboratory materials, and networked professional services working seamlessly with the goal of improving patient care. Access Genetics collapses time and distance through technology and shared expertise to get the right answers to health care providers and patients faster. Our business model is unique and provides our laboratory customers and physicians to become experts in molecular diagnostics and rapidly expand their offering of high value, in house genetic tests. Our CLIA and CAP certified high complexity clinical laboratory provides backup and peak needs support.